Skip to main content
Premium Trial:

Request an Annual Quote

Power3 Hires Middle East Distributor for Proteomic-Based Breast Cancer Dx

NEW YORK (GenomeWeb News) — Power3 Medical Products said yesterday it has hired Bahrain-based Financial Advisory House to market and distribute a proteomics-based breast cancer test in 12 countries in the Middle East.
 
Under the agreement, FAH’s Medical Equipment Suppliers division will market and distribute Power3’s BC-SeraPro breast cancer diagnostic in Bahrain; Egypt; Iraq; Jordan; Kuwait; Lebanon; Saudi Arabia; Oman; Qatar; Syria; the United Arab Emirates; and Yemen.
 
BC-SeraPro is a proteomics-based blood serum diagnostic used for the early screening and diagnosis of breast cancer. FAH will market and distribute it to clinics and physicians in these countries, while the tests will be analyzed in Power3's Houston-based CLIA lab.
 
Financial terms of the agreement were not released.
 
“We selected the Middle East as our initial market because the healthcare systems in these particular countries are open to providing a test that offers new and innovative technologies for earlier detection of breast cancer,”Power3 CEO Steven Rash said in a statement.
 
The company also is seeking other distributors for the blood serum-based breast cancer test and is involved in discussions with international and domestic partners, it said.

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.